Serum FABP1 levels are used to monitor fibrosis and hepatocellular damage during liver surgery 28 in both patients with hepatitis C virus (HCV) 16 and NASH patients 17. This evidence concerns the gene FABP1 and metabolic dysfunction-associated steatohepatitis.